- Home
- PTY vs ALVO Comparison
PTY vs ALVO Comparison
Compare PTY & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTY
- ALVO
- Stock Information
- Founded
- PTY 2002
- ALVO 2013
- Country
- PTY United States
- ALVO Luxembourg
- Employees
- PTY N/A
- ALVO N/A
- Industry
- PTY Investment Managers
- ALVO Biotechnology: Pharmaceutical Preparations
- Sector
- PTY Finance
- ALVO Health Care
- Exchange
- PTY Nasdaq
- ALVO Nasdaq
- Market Cap
- PTY 2.8B
- ALVO 2.5B
- IPO Year
- PTY N/A
- ALVO N/A
- Fundamental
- Price
- PTY $13.61
- ALVO $5.51
- Analyst Decision
- PTY
- ALVO Buy
- Analyst Count
- PTY 0
- ALVO 2
- Target Price
- PTY N/A
- ALVO $11.00
- AVG Volume (30 Days)
- PTY 550.4K
- ALVO 685.2K
- Earning Date
- PTY 01-01-0001
- ALVO 11-12-2025
- Dividend Yield
- PTY 9.65%
- ALVO N/A
- EPS Growth
- PTY N/A
- ALVO N/A
- EPS
- PTY N/A
- ALVO 0.22
- Revenue
- PTY N/A
- ALVO $562,478,000.00
- Revenue This Year
- PTY N/A
- ALVO $34.94
- Revenue Next Year
- PTY N/A
- ALVO $39.55
- P/E Ratio
- PTY N/A
- ALVO $23.26
- Revenue Growth
- PTY N/A
- ALVO 82.19
- 52 Week Low
- PTY $11.92
- ALVO $4.70
- 52 Week High
- PTY $14.88
- ALVO $13.70
- Technical
- Relative Strength Index (RSI)
- PTY 38.03
- ALVO 29.77
- Support Level
- PTY $13.65
- ALVO $4.70
- Resistance Level
- PTY $13.78
- ALVO $8.50
- Average True Range (ATR)
- PTY 0.18
- ALVO 0.33
- MACD
- PTY -0.00
- ALVO -0.34
- Stochastic Oscillator
- PTY 61.59
- ALVO 21.69
About PTY Pimco Corporate & Income Opportunity Fund
PIMCO Corporate & Income Opportunity Fds operates as a closed-end management investment company. It seeks to maximize total return through a combination of current income and capital appreciation. The fund invests a majority of the total assets in a combination of corporate debt obligations of varying maturities, other corporate income-producing securities, and income-producing securities of non-corporate issuers, such as U.S. Government securities, municipal securities, and mortgage-backed and other asset-backed securities issued on a public or private basis.
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.